Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

Zhang, Xinmei, Yeung, Dennis C.Y., Karpisek, Michal, Stejskal, David, Zhou, Zhi-Guang, Liu, Feng, Wong, Rachel L.C., Chow, Wing-Sun +3 more·2008·Diabetes

Cited by (907)

Items 601–700 of 907

  1. From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk
    Rafael Romero-Becerra, Ayelén Melina Santamans, Alba C. Arcones, Guadalupe Sabio · 2023 · Physiology
  2. KLOTHO, FGF21 AND FGF23: NOVEL PATHWAYS TO MUSCULOSKELETAL HEALTH?
    Benedetta Bartali, Richard D. Semba, André Brandão de Araújo · 2013 · The Journal of Frailty & Aging
  3. Fibroblast growth factor 21 and fructose dynamics in humans
    Alexandra L. Migdal, Sylvain Comte, Megan Rodgers, Brent D. Heineman, Eleftheria Maratos–Flier, Mark A. Herman, Jody R. Dushay · 2018 · Obesity Science & Practice
  4. Prognostic value of plasma fibroblast growth factor 21 among patients with acute ischemic stroke
    Xiaowei Zheng, Zhengbao Zhu, Daoxia Guo, Chongke Zhong, Tan Xu, Yanbo Peng, Aili Wang, Hao Yang Peng, Zhong Ju, Deqin Geng et al. · 2020 · European Journal of Neurology
  5. Association between serum fibroblast growth factor 21 level and sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes
    Shi Jin, Ning Xia, Lingling Han · 2021 · BMJ Open Diabetes Research & Care
  6. The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine
    Philipp Burow, Marc Haselier, Steffen Naegel, Leila Motlagh Scholle, Charly Gaul, Torsten Kraya · 2021 · Cells
  7. FTO and PLAG1 Genes Expression and FTO Methylation Predict Changes in Circulating Levels of Adipokines and Gastrointestinal Peptides in Children
    Wojciech Czogała, Wojciech Strojny, Magdalena Schab, Agnieszka K. Grabowska, Karol Dominik Miklusiak, Wojciech Kowalczyk, Agnieszka Łazarczyk, Przemysław Tomasik, Szymon Skoczeń · 2021 · Nutrients
  8. Brain-acting hepatokines: its impact on energy balance and metabolism
    Lucía Giovanini, Nahuel Ezequiel Wanionok, Mario Perelló, María Paula Cornejo · 2025 · Frontiers in Neuroscience
  9. FGF family in health and disease
    Xiaoyu Liu, Meiling Jing, Yueyi Yang, Qiaoqiao Jin, Bo Feng, Pengfei Zhang, Chenguang Niu, Xuchen Hu, Zhengwei Huang · 2026 · Molecular Biomedicine
  10. Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis
    Yong Gang Guo, Ling Li, Shanbiao Hu · 2023 · Renal Failure
  11. The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
    Mada Ghanem, Gabrielle Archer, Bruno Crestani, Arnaud Mailleux · 2024 · Pharmacology & Therapeutics
  12. Plasma levels and leucocyte RNA expression of adipokines in young patients with coronary artery disease, in metabolic syndrome and healthy controls
    Aleš Smékal, Jan Václavík, David Stejskal, Klára Benešová, Jiří Jarkovský, Gabriela Svobodová, Radmila Richterová, Marek Švesták, Miloš Táborský · 2017 · Cytokine
  13. Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease
    Miguel Ángel Gómez-Sámano, Valerie Paola Vargas-Abonce, Froylan David Martínez‐Sánchez, Lucía Palacios-Báez, Juan Mauricio Vera-Zertuche, María Fernanda Navarro-Flores, Mariana Morales-García, Jorge Ignacio Fonseca-Correa, Julia María Zuarth-Vázquez, Olynka Vega‐Vega et al. · 2021 · Therapeutic Advances in Endocrinology and Metabolism
  14. Fibroblast growth factor-21 (FGF21) analogs as possible treatment options for diabetes mellitus in veterinary patients
    Ronald Jan Corbee, Dion L. van Everdingen, H.S. Kooistra, Louis C. Penning · 2023 · Frontiers in Veterinary Science
  15. Sesamol promotes browning of white adipocytes through liver-adipose crosstalk signal of hepatic fibroblast growth factor 21.
    Ming-Hui Cheng, Wenya Zheng, Quan Zhang, Zhu Liu, Jing-Fang Chen, Mahnoor Atta, Hong Qin · 2023 · Journal of Nutritional Biochemistry
  16. LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis
    Bing Liu, Yi Zhong, Dandan Huang, Liuye Yang, Pengchao Wang, Yang Liu, Fengxiao Zhang, Xiaoguang Li, Minglu Liang, Kai Huang et al. · 2023 · Metabolism
  17. Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis
    Lucas Zangerolamo, Marina Uchôa Wall Barbosa De Carvalho, Licio Augusto Velloso, Helena C.L. Barbosa · 2023 · European Journal of Pharmacology
  18. Effects of omega-3 fatty acids and pioglitazone combination on insulin resistance through fibroblast growth factor 21 in type 2 diabetes mellitus
    Laila Ahmed Eissa, Noha Abdel‐Rahman, Salma M. Eraky · 2015 · Egyptian Journal of Basic and Applied Sciences
  19. Expression of fibroblast growth factor 21 in patients with biliary atresia
    Dawei Li, Tianfei Lu, Conghuan Shen, Yuan Liu, Jiang Zhang, Yuhua Shan, Yi Luo, Zhifeng Xi, Bijun Qiu, Qimin Chen et al. · 2016 · Cytokine
  20. Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status
    Kaveri Pathak, Mário J. Soares, Yun Zhao, Anthony Paul James, Jillian L. Sherriff, Philip Newsholme · 2016 · Nutrition
  21. Role of Omega-3-Fatty Acids in the Management of Diabetes and Associated Complications
    Tapan Behl, Madhuri Grover, Karan Shah, Rashita Makkar, Loveleen Kaur, Shivali Sharma, Jyoti Gupta · 2019 · Elsevier eBooks
  22. Adipose-derived lipocalin 14 alleviates hyperglycaemia by suppressing both adipocyte glycerol efflux and hepatic gluconeogenesis in mice
    Jimmy Tsz Hang Lee, Zhe Ping Huang, Kewu Pan, Herbert Jialiang Zhang, Connie W. Woo, Aimin Xu, Chi‐Ming Wong · 2015 · Diabetologia
  23. Altered Red Blood Cell Fatty Acid and Serum Adipokine Profiles in Subjects with Obesity
    Asier Léniz, Alfredo Fernández‐Quintela, Sara Arranz, Kevin Joseph Portune, Itziar Tueros, Eunate Arana‐Arri, Luis Antonio Castaño, Olaia Velasco, María P. Portillo · 2023 · Biomedicines
  24. The role of FGF21 in the interplay between obesity and non-alcoholic fatty liver disease: a narrative review
    Cristina Elena Negroiu, Iulia Tudorașcu, Maria Cristina Beznă, Adrian Ungureanu, Sorina Octavia Honţaru, Suzana Dănoiu · 2024 · Romanian Journal of Morphology and Embryology
  25. Parsing the Potential Neuroendocrine Actions of FGF21 in Primates
    Matthew Paul Gillum · 2018 · Endocrinology
  26. Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis
    Joshua F. Baker, James R. O’Dell, Bryant R. England, Jon T. Giles, Jeff A. Newcomb, Michael George, Geoffrey M. Thiele, Larry W. Moreland, S. Louis Bridges, Jeffrey R. Curtis et al. · 2024 · Annals of the Rheumatic Diseases
  27. Soluble C-X-C chemokine ligand 16 levels are increased in gout patients
    Qi Gong, Fan Wu, Xuebo Pan, Jiawen Yu, Yilan Li, Tingting Lu, Xiaokun Li, Zhuofeng Lin · 2012 · Clinical Biochemistry
  28. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease
    David E. Amacher · 2014 · Biomarkers
  29. Practical prospects for boosting hepatic production of the “pro-longevity” hormone FGF21
    Mark Frederick McCarty · 2015 · Hormone Molecular Biology and Clinical Investigation
  30. Effects of Bariatric Surgeries on Fetuin-A, Selenoprotein P, Angiopoietin-Like Protein 6, and Fibroblast Growth Factor 21 Concentration
    Jakub Poloczek, Wojciech Kazura, Ewa Kwaśnicka, Janusz Gumprecht, Jerzy Jochem, Dominika Marta Stygar · 2021 · Journal of Diabetes Research
  31. Mapping the response of human fibroblast growth factor 21 (FGF21) promoter to serum availability and lipoic acid in HepG2 hepatoma cells
    Mengna Xia, Anjeza Erickson, Xiaohua Yi, Régis F. Moreau · 2015 · Biochimica et Biophysica Acta (BBA) - General Subjects
  32. Highly Selective and Sensitive Measurement of Active forms of FGF21 Using Novel Immunocapture Enrichment with LC–MS/MS
    Yue Zhao, Guowen Liu, Suk Kwok, Barry R. Jones, Jane Liu, David Marchisin, Philip Joyce, Jon E. Peterson, Jim Xiangxin Shen · 2017 · Bioanalysis
  33. Mitiglinide treatment may decreases plasma fibroblast growth factor-21 levels in individuals with new-onset T2DM
    Bo Wang, Gangyi Yang, Mengliu Yang, Yong Liao, Zhiyong Li, Guenther H. Boden, Ling Li · 2011 · Cytokine
  34. Effects of intermittent fasting on liver steatosis and fibrosis, serum FGF-21 and autophagy markers in metabolic dysfunction-associated fatty liver disease: a randomized controlled trial
    Ozlu Karahan, Tugce, Yilmaz Akyuz, Elvan, Yilmaz Karadag, Demet, Yilmaz, Yusuf, Eren, Fatih · 2025 · Life
  35. Maternal overweight and obesity modify the association of serum fibroblast growth factor 21 levels with gestational diabetes mellitus: A nested case‐control study
    Ping Wu, Linjing Wu, Yi Wang, Yi Ye, Xue Yang, Jiaying Yuan, Jianguo Xu, Yixin Wang, Xingyue Song, Shijiao Yan et al. · 2023 · Diabetes/Metabolism Research and Reviews
  36. Role of the serum levels of the inter-organs messenger fibroblast growth factor 21 (FGF21) in the diagnosis and prognosis of breast cancer patients
    Stella Maris Ranuncolo, Eduardo Armanasco, Myriam Núñez, Laura Yuan, Sujhrob Makhkamov, Mariana S. De Lorenzo · 2025 · Cell Communication and Signaling
  37. Research progress on the role of FGF21 in insulin resistance
    Haixin Zhang, Rongyu Zhu, Quanhao Sun, Likun Du · 2025 · Frontiers in Endocrinology
  38. Transgenic mice specifically expressing amphiregulin in white adipose tissue showed less adipose tissue mass
    Bo Yang, Takahiro Kumoto, Takeshi Arima, Minako Nakamura, Yohei Sanada, Thanutchaporn Kumrungsee, Yusuke Sotomaru, Masayuki Shimada, Noriyuki Yanaka · 2018 · Genes to Cells
  39. A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents
    Ghada El Sagheer, Asmaa Ahmad, Aliaa Abd-ElFattah, Zienab M Saad, Lamia Hamdi · 2018 · Clinical and Experimental Gastroenterology
  40. Physical Exercise-Induced FGF-21 to Fight Obesity: An Update Review
    Bruno Vecchiatto, Thiago Lucas de Castro, Cynthia R. Muller, Anna Karenina Azevedo‐Martins, Fabiana S. Evangelista · 2022 · Obesities
  41. Effects of FGF21 overexpression in osteoporosis and bone mineral density: a two-sample, mediating Mendelian analysis
    Jingjing Liu, Jun Jiang, Yunjia Li, Qiaojun Chen, Ting Yang, Yanfa Lei, Zewei He, Xiaowei Wang, Qiang Na, Changtao Lao et al. · 2024 · Frontiers in Endocrinology
  42. Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
    Kelvin H. M. Kwok, Karen S.L. Lam · 2017 · Endocrinology and Metabolism
  43. Differences in the inflammatory proteome of East African and Western European adults and associations with environmental and dietary factors
    Godfrey S. Temba, Nadira Vadaq, Vesla I. Kullaya, Tal Pecht, Paolo Lionetti, Duccio Cavalieri, Joachim Ludwig Schultze, Reginald Adolph Kavishe, Leo A. B. Joosten, André J. A. M. van der Ven et al. · 2023 · eLife
  44. Ingestion of eicosapentaenoic acid in the early stage of social isolation reduces a fibroblast growth factor 21 resistant state independently of body weight in KKAy mice
    Katsunori Nonogaki, Tomoe Yamazaki, Mari Murakami, Takao Kaji · 2015 · Biochemical and Biophysical Research Communications
  45. Fasting Insulin and Alanine Amino Transferase, but not FGF21, Were Independent Parameters Related with Irisin Increment after Intensive Aerobic Exercising
    Viridiana Abigahy de la Torre-Saldaña, Miguel Ángel Gómez-Sámano, Francisco Javier Gomez-Perez, Juan Rosas-Saucedo, Andrés León‐Suárez, Mariana Grajales-Gómez, Jorge Oseguera-Moguel, Arturo Vega‐Beyhart, Daniel Cuevas Ramos · 2019 · Revista de investigaci�n Cl�nica
  46. Hepatokine‐based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients
    Martin Franck, Katharina John, Sherin Al Aoua, Monika Rau, Andreas Geier, Jörn Markus Schattenberg, Heiner H. Wedemeyer, Klaus Schulze‐Osthoff, Heike Bantel · 2023 · Liver International
  47. Immunometabolic blood biomarkers of developmental trajectories of depressive symptoms: findings from the ALSPAC birth cohort
    Ruby S. M. Tsang, Daniel Stow, Alex S. F. Kwong, Nicholas A Donnelly, Holly Fraser, Inês Barroso, Peter Holmans, Michael John Owen, Megan Louise Wood, George Kirov et al. · 2025 · Molecular Psychiatry
  48. The relationship of circulating fibroblast growth factor 21 levels with pericardial fat: The Multi-Ethnic Study of Atherosclerosis
    Arsenios Magdas, Jingzhong Ding, Robyn L. McClelland, Matthew Allison, Philip J. Barter, Kerry‐Anne Rye, Kwok Leung Ong · 2019 · Scientific Reports
  49. Fibroblast Growth Factor 21 Is Elevated in HIV and Associated With Interleukin-6
    Allison Ross Eckard, Heather Hughes, Nancy L. Hagood, Mary Ann O’Riordan, Danielle E. Labbato, Julia C. Kosco, Sarah Scott, Grace A. McComsey · 2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  50. Adipokines in pulmonary hypertension: angels or demons?
    Qi Jia, Yeling Ouyang, Yiyi Yang, Shanglong Yao, Xiangdong Chen, Zhiqiang Hu · 2023 · Heliyon
  51. Insulin resistance in adolescents with Turner syndrome is comparable to obese peers, but the overall metabolic risk is lower due to unknown mechanism
    Małgorzata Wójcik, Dominika Januś, Agata Zygmunt-Górska, Jerzy Starzyk · 2014 · Journal of Endocrinological Investigation
  52. Serum Levels of Fibroblast Growth Factor 21 in Type 2 Diabetic Patient
    Yunes Panahi · 2016 · Acta Endocrinologica (Bucharest)
  53. Relationship between family history of type 2 diabetes and serum FGF 21
    Greggory R. Davis, Tiffany Deville, Joshua Guillory, David Michael Bellar, Arnold G. Nelson · 2017 · European Journal of Clinical Investigation
  54. Identification and expression patterns of adipokine genes during adipocyte differentiation in the Tibetan goat ( Capra hircus )
    Xueying Li, Yan Wang, Jiazhong Guo, Tao Zhong, Li Li, Hongping Zhang, Linjie Wang · 2017 · Gene
  55. Changes in Liver Gene Expression and Plasma Concentration of Rbp4, Fetuin-A, and Fgf21 in Sprague-Dawley Rats Subjected to Different Dietary Interventions and Bariatric Surgery
    Dominika Marta Stygar, Wojciech Pigłowski, Elżbieta Chełmecka, Bronisława Skrzep-Poloczek, Tomasz Sawczyn, Wojciech Garłowski, Jerzy Jochem, Konrad Wojciech Karcz · 2018 · BioMed Research International
  56. Differential effects of protein intake versus intake of a defined oligopeptide on FGF-21 in obese human subjects in vivo
    Daniela Fangmann, Corinna Geisler, Kristina Schlicht, Katharina Hartmann, Jana Köpke, A Tiede, Ute Settgast, Kathrin Türk, Dominik Maria Schulte, Karina Altmann et al. · 2020 · Clinical Nutrition
  57. Impact of sex on the adaptation of adult mice to long consumption of sweet-fat diet
    Н. М. Бажан, Tatiana Iakovleva, Anastasia Dubinina, Makarova En · 2020 · Vavilov Journal of Genetics and Breeding
  58. Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease
    Cortney N. Steele, Kristen L. Nowak · 2022 · Kidney and Dialysis
  59. Synbiotics intake improves disturbed metabolism in a rat model of high fat diet-induced obesity; A potential role of adipose tissue browning
    Hala Mahmoud, Reem M. Sallam, Christeen Medhat Ayad Henin, Amr Soliman Moustafa, Reham Hussein Mohamed, Magda I. Mohamad · 2022 · Obesity Medicine
  60. Dietary intervention improves health metrics and life expectancy of the genetically obese Titan mouse
    Annika Müller-Eigner, Adrián Sanz‐Moreno, Irene de Diego, Anuroop Venkateswaran Venkatasubramani, Martina Langhammer, Raffaele Gerlini, Birgit Rathkolb, Juan Antonio Aguilar‐Pimentel, Tanja Klein‐Rodewald, Julia Calzada‐Wack et al. · 2022 · Communications Biology
  61. Do Sugar-Sweetened Beverages Increase Fasting FGF21 Irrespective of the Type of Added Sugar? A Secondary Exploratory Analysis of a Randomized Controlled Trial
    Bettina Geidl, Michel Hochuli, Giatgen A. Spinas, Philipp A. Gerber · 2022 · Nutrients
  62. Fibroblast growth factor-21 and Visfatin as potential predictors for metabolic risk factors in obese children
    Sahar A. El-Masry, Maisa Nasr Farid, Nayera E. Hassan, Muhammad Al-Tohamy, Lamis H Mekkawy, Galal Ismail Ahmed Elashry, Safa Nabil Abd El-Fattah · 2024 · Scientific Reports
  63. Elevated serum fibroblast growth factor 21 levels correlate with immune recovery but not mitochondrial dysfunction in HIV infection
    Brendan A. I. Payne, David Price, Patrick Francis Chinnery · 2013 · AIDS Research and Therapy
  64. Fibroblast growth factor 21 – a key player in cardiovascular disorders?
    Monika Lenart-Lipińska, Dariusz Duma, Magdalena Hałabiś, Marcin Dziedzic, Janusz Solski · 2016 · Hormone Molecular Biology and Clinical Investigation
  65. Effects of beta-conglycinin intake on circulating FGF21 levels and brown adipose tissue activity in Japanese young men: a single intake study and a randomized controlled trial
    Hirokazu Taniguchi, Keigo Shimizu, Sayori Wada, Shinsuke Nirengi, Haruki Kataoka, Akane Higashi · 2020 · Journal of PHYSIOLOGICAL ANTHROPOLOGY
  66. Lack of Day/Night variation in fibroblast growth factor 21 levels in young healthy men
    Joo‐Pin Foo, Konstantinos N. Aronis, John P. Chamberland, Christos Socrates Mantzoros · 2014 · International Journal of Obesity
  67. Adiposity Is a Key Correlate of Circulating Fibroblast Growth Factor-21 Levels in African Males with or without Type 2 Diabetes Mellitus
    Fredirick L. Mashili, Kaushik L. Ramaiya, Janet K. Lutale, Marina Alois Njelekela, Filbert T. Francis, Juleen Rae Zierath, Anna Krook · 2018 · Journal of Obesity
  68. A Chronic GM(2) Gangliosidosis Variant with a HEXA Splicing Defect: Quantitation of HEXA mRNAs in Normal and Mutant Fibroblasts
    Mauro Juarez Fernandes, Peter Hechtman, Bernard Boulay, Feige Kaplan · 1997 · European Journal of Human Genetics
  69. Commentary: FGF21 Holds Promises for Treating Obesity-related Insulin Resistance and Hepatosteatosis
    Anna Alisi, Nadia Panera, Valério Nobili · 2013 · Endocrinology
  70. Mitochondrial and psychosocial stress-related regulation of FGF21 in humans
    Mangesh Kurade, Natalia Bobba‐Alves, Catherine A. Kelly, Alexander Behnke, Quinn A. Conklin, Robert‐Paul Juster, Michio Hirano, Caroline Trumpff, Martin A. Picard · 2025 · Nature Metabolism
  71. The Regulation of Circulating Hepatokines by Fructose Ingestion in Humans
    Michael M. Richter, Peter Plomgaard · 2021 · Journal of the Endocrine Society
  72. Relationship Between the Serum FGF21 Level and Growth in Children of Short Stature
    Yun Jeong Lee, So Yoon Jung, Young Ah Lee, Jae Hyun Kim, Seong Yong Lee, Choong Ho Shin · 2023 · Journal of Korean Medical Science
  73. Serum Fibroblast Growth Factor 21 Level After an Oral Fat Tolerance Test is Related to Postprandial Free Fatty Acid Level
    Xiaolong Li, Kunjie Zheng, Wei Gu, Xiaoyu Hou, Yunpeng Guan, Lifang Liu, Liping Hou, Jianlin Geng, Guangyao Song · 2023 · Diabetes Metabolic Syndrome and Obesity
  74. Prevalence and Crucial Parameters in Diabesity-Related Liver Fibrosis: A Preliminary Study
    Szymon Suwała, Aleksandra Białczyk, Kinga Koperska, Alicja Rajewska, Magdalena Krintus, Roman Junik · 2023 · Journal of Clinical Medicine
  75. Defective FGFR1 Signaling Disrupts Glucose Regulation: Evidence From Humans With FGFR1 Mutations
    Maria I. Stamou, Crystal J Chiu, Shreya V. Jadhav, Vanessa Ferreira Lopes, Kathryn B. Salnikov, Lacey Plummer, Margaret Flynn Lippincott, Hang Lee, Stephanie Beth Seminara, Ravikumar Balasubramanian · 2024 · Journal of the Endocrine Society
  76. Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes
    Jingyi Lu, Haoyong Yu, Yifei Mo, Xiaojing Ma, Yaping Hao, Wei Lu, Huating Li, Yuqian Bao, Jian Zhou, Weiping Jia · 2015 · PLoS ONE
  77. Fasting and glucose induced thermogenesis in response to three ambient temperatures: a randomized crossover trial in the metabolic syndrome
    Kaveri Pathak, Richard John Woodman, Anthony Paul James, Mário J. Soares · 2018 · European Journal of Clinical Nutrition
  78. Roles of FGF21 and irisin in obesity-related diabetes and pancreatic diseases
    Ting Xie, Po Sing Leung · 2020 · Journal of Pancreatology
  79. Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus
    Hirokazu Taniguchi, Shinsuke Nirengi, Kengo Ishihara, Naoki Sakane · 2022 · PLoS ONE
  80. FGF21 response to sucrose is associated with BMI and dorsal striatal signaling in humans
    Jasmin M. Alves, Alexandra Grace Yunker, SHAN H. LUO, Kay Jann, BRENDAN C. ANGELO, ALEXIS W. DEFENDIS, Trevor A. Pickering, Alexandro Smith, John R. Monterosso, Kathleen A. Page · 2022 · Obesity
  81. Association of serum fibroblast growth factor 21 levels with skeletal muscle mass and mortality in chronic hemodialysis patients
    Liang-Te Chiu, Chih‐Hsien Wang, Yu‐Li Lin, Bang‐Gee Hsu · 2022 · Journal of the Formosan Medical Association
  82. Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
    Min-Qi Jia, Cha‐Xiang Guan, Jia‐Hao Tao, Yong Zhou · 2022 · Oxidative Medicine and Cellular Longevity
  83. Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?
    Stefano Benedini, Livio Luzi · 2016 · Journal of Translational Internal Medicine
  84. Rapamycin‐ameliorated diabetic symptoms involved in increasing adiponectin expression in diabetic mice on a high‐fat diet
    Fanghua Gong, Yanna Ye, Jinmeng Li, Haiyang Zhao, Xiaokun Li · 2017 · The Kaohsiung Journal of Medical Sciences
  85. Sex-specific association between fibroblast growth factor 21 and type 2 diabetes: a nested case-control study in Singapore Chinese men and women
    Yeli Wang, Woon‐Puay Koh, Jian‐Min Yuan, An Pan · 2017 · Nutrition & Metabolism
  86. Red raspberry (poly)phenolic extract improves diet-induced obesity, hepatic steatosis and insulin resistance in obese mice
    Haizhao Song, Xinchun Shen, Qiang Chu, Xiaodong Zheng · 2021 · Journal of Berry Research
  87. Fibroblast Growth Factor 21 as a Potential Biomarker for Improved Locomotion and Olfaction Detection Ability after Weight Reduction in Obese Mice
    Nicole Power Guerra, Alisha Parveen, Daniel Bühler, David Brauer, Luisa Müller, Kristin Pilz, Martin Witt, Anne S. Glass, Rika Bajorat, Deborah Janowitz et al. · 2021 · Nutrients
  88. Novel Adipokines CTRP1, CTRP9, and FGF21 in Pediatric Type 1 and Type 2 Diabetes: A Cross-Sectional Analysis
    Alexander Arking, Dylan C. Sarver, Sheela Natesh Magge, Guang William Wong, Risa M. Wolf · 2022 · Hormone Research in Paediatrics
  89. Serum FGF21 Levels Predict the MACE in Patients With Myocardial Infarction After Coronary Artery Bypass Graft Surgery
    Wei Xie, Dan Li, Yaru Shi, Yu Ning, Yu Yan, Yingchao Zhang, Qiongli Yu, Yulin Li, Jie Du, Zhuofeng Lin et al. · 2022 · Frontiers in Cardiovascular Medicine
  90. Adipose Tissue as an Endocrine Organ
    Hannah Hui, Tianshi Feng · 2018 · InTech eBooks
  91. Fibroblast Growth Factor 21, Adiponectin, and Irisin as Markers of Unfavorable Metabolic Features in 12-Year-Old Children
    Satu Seppä, Sirpa Tenhola, Raimo Voutilainen · 2019 · Journal of the Endocrine Society
  92. Impact of sleep restriction on biomarkers of thyroid function: Two pooled randomized trials
    Megan E. Ruiter Petrov, Faris M. Zuraikat, Bin Cheng, Brooke Aggarwal, Sanja Jelić, Blandine Laferrère, Marie‐Pierre St‐Onge · 2024 · Sleep Medicine
  93. The association between circulating irisin, osteocalcin and FGF21 levels with anthropometric characteristics and blood lipid profile in young obese male subjects
    Sema Etiz Sayharman, Muaz Belviranlı, Nilsel Okudan · 2025 · Advances in Medical Sciences
  94. Fıbroblast growth factor 21 and ıts relatıonshıp wıth ınsulın sensıtıvıty ın fırst-degree relatıves of patıents wıth type 2 dıabetes mellıtus
    Damla Ors, Alev Eroğlu Altınova, Mehmet Muhittin Yalçın, Özlem Gülbahar, Müjde Aktürk, Metin Arslan, Füsun Baloş Törüner · 2015 · Endokrynologia Polska
  95. Obesity-resistance of UCP1-deficient mice associates with sustained FGF21 sensitivity in inguinal adipose tissue
    Marlou Klein Hazebroek, Susanne Keipert · 2022 · Frontiers in Endocrinology
  96. Inflammatory biomarkers after an exercise intervention in childhood acute lymphoblastic leukemia survivors
    Tuomas Lähteenmäki Taalas, Liisa S. Järvelä, Harri Niinikoski, Anu Huurre, Arja H. Harila‐Saari · 2022 · eJHaem
  97. A Comprehensive Review on the Metabolic Cooperation Role of Nuclear Factor E2-Related Factor 2 and Fibroblast Growth Factor 21 against Homeostasis Changes in Diabetes
    Bahar Kiani, Sahar Yarahmadi, Mohsen Nabi‐Afjadi, Hanie Eskandari, Maryam Hasani, Zahra Abbasian, Elham Bahreini · 2022 · Clinical Diabetology
  98. Fibroblast growth factor 21 is an independent predictor of prevalent and incident obstructive sleep apnea
    Weijun Huang, Jingyu Zhang, Jianyin Zou, Xiaoting Wang, Huajun Xu, Jian Guan, Hongliang Yi, Suru Liu, Shankai Yin · 2023 · iScience
  99. Hepatic-Specific FGF21 Knockout Abrogates Ovariectomy-Induced Obesity by Reversing Corticosterone Production
    Jiayu Xu, Xinyu Shao, Haozhe Zeng, Chengxi Wang, Jiayi Li, Xiaoqin Peng, Yong Zhuo, Lun Hua, Fengyan Meng, Xingfa Han · 2023 · International Journal of Molecular Sciences
  100. Metabolically healthy obesity in adults with X-linked hypophosphatemia
    Anne-Lise Lecoq, Katharina Schilbach, L. Rocher, Séverine Trabado, Karine Briot, Julia Herrou, Aurélie Forbes, Anthony Garnier, Marie‐Liesse Piketty, Martin Bidlingmaier et al. · 2024 · European Journal of Endocrinology